Back
Sunshine Biopharma Quote, Financials, Valuation and Earnings
Sponsored
SBFM
Sponsored
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
SBFM
Sunshine Biopharma
Last Price:
3.15
Seasonality Move:
-20.95%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!Sunshine Biopharma Price Quote
$3.15
+0.17 (+5.87%)
(Updated: October 4, 2024 at 6:55 PM ET)
Sunshine Biopharma Key Stats
Sell
22
Sunshine Biopharma (SBFM)
is a Sell
Day range:
$2.91 - $3.05
52-week range:
$2.42 - $740.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.13
P/B ratio:
0.16%
Volume:
46.1K
Avg. volume:
232.5K
1-year change:
-99.51%
Market cap:
$3.8M
Revenue:
$24.1M
EPS:
$-234.1
How Much Does Sunshine Biopharma Make?
-
How Much Are Sunshine Biopharma's Sales Annually?
SBFM Revenues are $24.1M -
How Much Profit Does Sunshine Biopharma's Make A Year?
SBFM net income is -$4.5M
Is Sunshine Biopharma Growing As A Company?
-
What Is Sunshine Biopharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.67% -
What Is Sunshine Biopharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sunshine Biopharma Stock Price Performance
-
Did Sunshine Biopharma Stock Go Up Last Month?
Sunshine Biopharma share price went up by 5.13% last month -
Did SBFM's Share Price Rise Over The Last Year?
SBFM share price fell by -99.51% over the past 1 year
What Is Sunshine Biopharma 52-Week High & Low?
-
What Is Sunshine Biopharma’s 52-Week High Share Price?
Sunshine Biopharma has traded as high as $740.00 over the past 52 weeks -
What Is Sunshine Biopharma’s 52-Week Low Share Price?
Sunshine Biopharma has traded as low as $2.42 over the past 52 weeks
Sunshine Biopharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sunshine Biopharma?
-
How Much Debt Does Sunshine Biopharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Sunshine Biopharma Have?
Cash and short term investments quarterly total is $11.5M -
What Is Sunshine Biopharma’s Book Value Per Share?
Book value per share is 20.06
Is Sunshine Biopharma Cash Flow Positive?
-
What Is SBFM Cash Flow From Operations?
Cash flow from operations (TTM) is -$10.9M -
What Is Sunshine Biopharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.3M -
What Is Sunshine Biopharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.5M
Sunshine Biopharma Return On Invested Capital
-
Is Management Doing A Good Job?
SBFM return on invested capital is -16.06% -
What Is Sunshine Biopharma Return On Assets?
ROA measures how assets are converting to revenues and is -12.72% -
What Is SBFM Return On Equity?
ROE is a measure of profitability and is -16.06%
Sunshine Biopharma Earnings Date & Stock Price
-
What Is Sunshine Biopharma's Stock Price Today?
A single share of SBFM can be purchased today for 2.98 -
What Is Sunshine Biopharma’s Stock Symbol?
Sunshine Biopharma trades on the nasdaq under the ticker symbol: SBFM -
When Is Sunshine Biopharma’s Next Earnings Date?
The next quarterly earnings date for Sunshine Biopharma is scheduled on November 13, 2024 -
When Is SBFM's next ex-dividend date?
Sunshine Biopharma's next ex-dividend date is October 5, 2024 -
How To Buy Sunshine Biopharma Stock?
You can buy Sunshine Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sunshine Biopharma Competitors
-
Who Are Sunshine Biopharma's Competitors?
Below is a list of companies who compete with Sunshine Biopharma or are related in some way:
Sunshine Biopharma Dividend Yield
-
What Is SBFM Dividend Yield?
Sunshine Biopharma’s dividend yield currently is 0% -
What Is Sunshine Biopharma’s Payout Ratio?
Sunshine Biopharma’s payout ratio is 0% -
When Did Sunshine Biopharma Last Pay A Dividend?
The latest dividend pay date is October 5, 2024 -
What Is Sunshine Biopharma’s Dividend Per Share?
Sunshine Biopharma pays a dividend of $0.00 per share
Sunshine Biopharma Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 67.3% | 3.37% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 300.00 |
Upside from Last Price: | 9983.02% |